In adjacent non-tumor tissues, the number of patients with SFRP1, SFRP2, and WIF1 methylation levels exceeding the cut-off value were 5 (2.7%), 7 (3.7%) and 41 (21.9%), respectively. The gene discussed is SFRP1; the disease is neoplasm.